California · Nonprofit
BREAST CANCER CARE & RESEARCH FUND
BREAST CANCER CARE & RESEARCH FUND (California) receives grants from 2 organizations whose IRS filings report $980 to it, the largest being SAM & SOOKY GOLDMAN CHARITABLE FOUNDATION INC ($500). 1 of them have funded it in more than one year.
- Revenue FY2024
- $23k
- Funders on record
- 2
- Grants received
- $980
- Net assets
- $141k
What Breast Cancer Care & Research Fund does
Mission
Breast Cancer Care & Research Funds mission is to eradicate breast cancer through education, research, advocacy and community outreach.
As stated on its FY2024 Form 990.
Programs
ADVOCACY: To empower women and men to become more actively involved in promoting clinical research trials and access to health care, and to have influence in every arena where breast cancer decisions are being made.
$3,655 spent33% of program spendingRESEARCH: To promote clinical research to improve treatments, discover the causes and how to prevent breast cancer
$0 spent0% of program spendingCOMMUNITY OUTREACH: To target minority communities, the underserved, young women living with breast cancer and metastatic patients.
$3,655 spent33% of program spendingEDUCATION: To educate women and men enabling them to gain knowledge of the disease of breast cancer so they can make a difference in their own lives and in the lives of others
$3,654 spent33% of program spending
The 4 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $10,964.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2019 to 2020, from $84k to $129k (+54%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
100% of BREAST CANCER CARE & RESEARCH FUND’s revenue is contributions — more reliant on donations than three-quarters of its peers (100% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Michele Rakoff
Executive Director
As listed on its FY2025 Form 990.
Who funds it, year by year
2018 → 2023: the base held at 1 funder, grant income fell $500 → $80.
1 of 2 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 49% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of BREAST CANCER CARE & RESEARCH FUND’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
BREAST CANCER CARE & RESEARCH FUND leans on a few funders — its largest provides 51% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
49% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund BREAST CANCER CARE & RESEARCH FUND.
Largest funder’s share by year: 2018 100% · 2020 100% · 2021 100% · 2022 100% · 2023 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
100% of BREAST CANCER CARE & RESEARCH FUND's grant income comes from California funders.
Funder states come from each funder’s own filing. $480 arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
BREAST CANCER CARE & RESEARCH FUND holds deeper cash reserves than three-quarters of the 9,898 health nonprofits its size.
this organization peer median middle 50% of peers· 9,898 health nonprofits under $100k, FY2024
Organizations like BREAST CANCER CARE & RESEARCH FUND
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
80% of spending goes to programs.
Governance
Public support
100%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for BREAST CANCER CARE & RESEARCH FUND: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds BREAST CANCER CARE & RESEARCH FUND?
- BREAST CANCER CARE & RESEARCH FUND (California) receives grants from 2 organizations whose IRS filings report $980 to it, the largest being SAM & SOOKY GOLDMAN CHARITABLE FOUNDATION INC ($500). 1 of them have funded it in more than one year.
- How many funders does BREAST CANCER CARE & RESEARCH FUND have?
- IRS filings report 2 organizations giving $980 in grants to BREAST CANCER CARE & RESEARCH FUND, 1 of which have funded it in more than one year.
- Who is the largest funder of BREAST CANCER CARE & RESEARCH FUND?
- SAM & SOOKY GOLDMAN CHARITABLE FOUNDATION INC is the largest funder on record, with $500 in grants. The full list of funders is on this page.
- How can an organization like BREAST CANCER CARE & RESEARCH FUND find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Breast Cancer Care & Research →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 2 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing